Outlook Therapeutics, Inc. logo

Outlook Therapeutics, Inc. Employee Directory

Biotechnology ResearchNew Jersey, United States51-200 Employees

Outlook Therapeutics, Inc. is a mid-sized biotechnology company based in Cranbury, New Jersey, focused on developing and commercializing ophthalmic therapies for retinal diseases. Its lead candidate, ONS-5010/LYTENAVA (bevacizumab gamma), is an ophthalmic formulation of bevacizumab intended for conditions such as wet age-related macular degeneration. LYTENAVA has received marketing authorization in the European Union and the United Kingdom for wet AMD, and the company plans a commercial launch in the EU and UK in the second quarter of 2025. In the United States, ONS-5010/LYTENAVA remains investigational, with a BLA resubmission to the FDA, and if approved would be the first ophthalmic bevacizumab formulation approved for retinal indications. The company operates in the biotechnology research sector with a focus on expanding access to bevacizumab-based retinal therapy through European distribution and potential U.S. approval. A recent development in its European expansion was an exclusive distribution agreement with Mediconsult AG for LYTENAVA in Switzerland, announced in 2026.

Find Outlook Therapeutics, Inc. employees' phone numbers or email addresses

Outlook Therapeutics, Inc. Global Highlights

Location
Employees

North America
54

Minus sign iconPlus sign icon
  • United States Of America
    54

Europe
21

Minus sign iconPlus sign icon
  • Germany
    12
  • United Kingdom Of Great Britain And Northern Ireland
    6
  • Switzerland
    2
  • Netherlands
    1

Asia
7

Minus sign iconPlus sign icon
  • India
    2
  • Jordan
    2
  • Bangladesh
    1
  • Cambodia
    1
  • Turkey
    1

Africa
2

Minus sign iconPlus sign icon
  • Ethiopia
    1
  • South Africa
    1

Outlook Therapeutics, Inc.'s Leadership

  • Stylized image of a person
    T. D.
    Chief Operations Officer
    Phone icon
  • Stylized image of a person
    F. J.
    Head Of Germany & Austria
    Phone icon
  • Stylized image of a person
    F. S.
    Chairman Of The Board Of Directors
    Phone icon
  • Stylized image of a person
    J. C.
    Svp Head Of Europe
    Phone icon
  • Stylized image of a person
    A. T.
    Senior Vice President
    Phone icon
  • Stylized image of a person
    O. T.
    Country Head, Dach
    Phone icon
  • Stylized image of a person
    D. S.
    Director, Process Engineering
    Phone icon
  • Stylized image of a person
    M. S.
    Medical Communications Lead Europe
    Phone icon

Outlook Therapeutics, Inc. Employee Metrics

100%
50%
0%
2026
2025
  • Entrepreneurship
  • Business
  • Education
  • Human Resources
  • Legal
  • Other
  • Sales
  • Administrative
  • Business Development

Contact profiles from Outlook Therapeutics, Inc.

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    C. P.
    Business Development Manager
    Phone icon
    United KingdomEngland
    Apr 06, 2026
  • Stylized image of a person
    S. H.
    Marketingmanager
    Phone icon
    GermanySchleswig-Holstein
    Apr 27, 2026
  • Stylized image of a person
    M. G. U. A.
    Member, Board Of Directors/ Aufsichtsratsmitglied
    Phone icon
    GermanyBaden-Württemberg
    Jun 19, 2026
  • Stylized image of a person
    Y. H.
    Board Member
    Phone icon
    Jordan
    Apr 06, 2026
  • Stylized image of a person
    B. A.
    Recruiting Specialist
    Phone icon
    Oct 23, 2024
  • Stylized image of a person
    P. S.
    Scientist I
    Phone icon
    Oct 24, 2024

Frequently Asked Questions

What is Outlook Therapeutics, Inc. known for?

Minus sign iconPlus sign icon
Outlook Therapeutics, Inc. was founded in 2011 operates in the Biotechnology Research industry. Explore Outlook Therapeutics, Inc.'s company overview page for more information.

What is Outlook Therapeutics, Inc.'s most common email format?

Minus sign iconPlus sign icon
Outlook Therapeutics, Inc. employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Outlook Therapeutics, Inc. email formats with LeadIQ.

How many employees does Outlook Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
Outlook Therapeutics, Inc. has approximately 60 employees as of July 2026. These team members are located across 4 continents, including North AmericaEuropeAsia.

Who are Outlook Therapeutics, Inc.'s key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, Outlook Therapeutics, Inc.'s key employees include:

  • Chief Operations Officer: T. D.
  • Head Of Germany & Austria: F. J.
  • Chairman Of The Board Of Directors: F. S.
  • Svp Head Of Europe: J. C.
  • Senior Vice President: A. T.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.